Life Science Case Studies

Determining Asset Strategy
A start-up biotech company was within a year of submitting an IND and needed to identify their lead indication among various potential oncology and autoimmune indications. In addition to identifying the lead indication, the client needed insight into when to partner and under what potential deal terms.

Applied Strategies worked with client teams and outside oncology and autoimmune experts to design development programs for each potential indication. Through facilitated workshops the teams identified the program risks and developed contingency plans based on the results of future clinical trials. We also provided insight into the risk and return of each program over the development timeframe for use by the business development group in partnering discussions.

<< back